Review and revision of guidelines for ovarian cancer treatment in Japan

Junzo Kigawa, Hidetaka Katabuchi, Nobuo Yaegashi

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)


A survey of members of the Japan Society of Gynecologic Oncology revealed that 93% of the members use the present Guideline for Ovarian Cancer Treatment in practice. There is an international consensus about first-line treatment for ovarian cancer. In contrast, the treatment for sex-cord stromal tumor, which is rare, and recurrent cancer are not standardized. In addition, management for borderline malignant tumor has been controversial. The new revision incorporates a new chapter regarding these matters. The revised Guideline may be more useful. We hope that re-examination and future revisions will be made to continually update the Guideline.

Original languageEnglish
Pages (from-to)617-619
Number of pages3
JournalJapanese Journal of Cancer and Chemotherapy
Issue number4
Publication statusPublished - 2010 Apr 6


  • Guideline
  • Ovarian cancer
  • Treatment

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Review and revision of guidelines for ovarian cancer treatment in Japan'. Together they form a unique fingerprint.

Cite this